Investment Pitches

Pitch Summary:
FSV detracted from performance after reporting third-quarter revenues below expectations despite meeting EPS estimates. Investor concerns centered on softer organic growth and near-term headwinds in certain service lines. While the recurring revenue model remains intact, sentiment reflected concern about near-term growth deceleration.

BSD Analysis:
FirstService operates essential property services that HOAs and homeowners can’t ignore. Recurring contracts create durable cash flow. Fragmentation provides acquisition opportunities. Weather and housing cycles add noise, not thesis breaks. Scale improves route density and margins. Investors undervalue boring service businesses consistently. Capital allocation has been disciplined. This compounds through maintenance, not growth hype. Real assets need care regardless of sentiment.

Pitch Summary:
CWAN shares surged following the announcement that the company would be acquired, driving a re-rating toward the transaction value. The acquisition highlighted the strategic value of Clearwater’s highly recurring revenue model and strong client retention. Its mission-critical role in institutional investment operations underpinned investor confidence.

BSD Analysis:
Clearwater sells investment accounting software where accuracy matters more than UI flair. Once installed, it becomes the system of record, making churn rare. Clients include insurers and asset managers with long lives and long contracts. Growth is steady, driven by asset complexity. Margins expand as implementations give way to subscription revenue. Investors dismiss Clearwater as slow SaaS. But regulation keeps demand sticky. Operating leverage improves quietly. This is financial infrastructure hiding in spreadsheets.

Pitch Summary:
CSW outperformed during the quarter despite reporting its first organic decline in twelve quarters within Contractor Solutions. The market looked through near-term weakness given the challenging residential HVAC environment. Performance was supported by an analyst upgrade and the acquisition of MARS Parts, which increased exposure to HVAC repair markets. Management continues to reposition the portfolio toward higher-quality, recurring end markets.

BSD Analysis:
CSW is a collection of niche industrial businesses optimized for margins, not headlines. Its products are small-ticket but mission-critical, enabling pricing power. End markets are fragmented, which favors disciplined operators. Acquisition strategy focuses on bolt-ons, not empire building. Investors overlook CSW because it lacks a story. But cash conversion is excellent. Cost discipline is cultural. Over cycles, ROIC does the talking. This is industrial compounding without drama.

Pitch Summary:
JKHY performed well after reporting solid fiscal first-quarter results characterized by steady top-line growth and successful contract wins for modernization solutions. Despite ongoing banking consolidation, the company continues to demonstrate strong client retention and long-term customer relationships. Investors favored its stable, essential growth profile late in the year. The company’s role as mission-critical infrastructure for financial institutions underpins durable earnings power.

BSD Analysis:
Jack Henry is embedded deep inside community banks and credit unions, making replacement a career-ending move for CIOs. Growth is slow, but revenue is sticky and predictable. Compliance complexity strengthens its moat every year. Digital add-ons expand wallet share without new customer wins. Investors worry about fintech disruption. Yet core processing is not optional experimentation. Margins reflect long-term contracts. Capital returns are steady and boring. This is financial plumbing that compounds quietly.

Pitch Summary:
RBC designs and manufactures precision bearings and engineered components for aerospace, defense, and industrial markets. The stock outperformed in 4Q25 as aerospace demand remained resilient and defense orders accelerated. Operating leverage drove margin expansion and investors reacted positively to strong free cash flow conversion. RBC’s exposure to long-cycle aerospace programs and mission-critical components supported earnings durability.

BSD Analysis:
RBC Bearings supplies precision components into aerospace and industrial systems where failure is unacceptable. Qualification cycles create switching costs that protect margins. Aerospace recovery timing drives sentiment more than fundamentals. Backlogs and content per aircraft continue rising. Industrial exposure adds diversification. Investors treat RBC like generic manufacturing. In reality, engineering depth is the moat. Cash generation improves as production rates normalize. This is high-barrier manufacturing with long-cycle leverage.

Pitch Summary:
RGEN supplies bioprocessing equipment and consumables used in biologic drug manufacturing. Shares rebounded strongly as evidence mounted that industry destocking had bottomed and order trends were stabilizing. Improved visibility into 2026 growth, combined with disciplined cost controls, drove operating leverage expectations higher. The market re-rated the stock as investors looked past near-term volatility and focused on RGEN’s high-quality consumables mix, strong market positions, and long-term biologics growth tailwinds.

BSD Analysis:
Repligen supplies critical components for biologics manufacturing where switching suppliers is risky and expensive. Biotech funding slowdowns hit volumes, but they don’t erase pipelines. Technical complexity creates pricing power most suppliers never see. Investors panic during destocking phases. But contamination risk keeps customers loyal. Margins reflect specialization, not scale hype. When biologics production restarts, demand rebounds sharply. Operating leverage cuts both ways. This is a life sciences tollbooth paused, not broken.

Pitch Summary:
Mesa Laboratories, Inc. (MLAB) was sold as operating results were pressured by end-market weakness, particularly in cell and gene therapy and in China. The company’s acquisition strategy has not delivered the growth initially anticipated, and limited organic growth opportunities constrain long-term prospects.

BSD Analysis:
Mesa Labs operates in the obscure but essential world of quality control and calibration, where failure is not tolerated. Its products are embedded in regulated environments like pharma, biotech, and healthcare. Growth has been uneven as acquisitions and integration added complexity. But the underlying demand for compliance never goes away. Recurring revenue and consumables provide a stabilizing base. Investors focus on execution noise and miss the durability of the end markets. Margins improve when integration settles, not when volumes spike. This is compliance infrastructure hiding behind a messy income statement. Fix execution, unlock value.

Pitch Summary:
Karman Holdings, Inc. (KRMN) is a defense technology company generating mid-teens organic revenue growth complemented by tuck-in M&A. Over 90% of revenue is IP protected and nearly 90% is sole-sourced, supporting strong competitive positioning.

BSD Analysis:
Karman is a niche aerospace and defense supplier benefiting from the reindustrialization of Western defense supply chains. Its value isn’t scale but certification, qualification, and long-standing customer relationships that are painfully hard to replace. Demand visibility is improving as defense budgets turn from rhetoric into contracts. Margins are driven by engineering content rather than raw materials. Investors often underestimate how sticky approved suppliers become once platforms enter production. Cyclicality exists, but program lives are measured in decades. Balance sheet discipline matters more than growth theatrics here. As capacity tightens, pricing power improves quietly. This is small-cap defense leverage with real barriers.

Pitch Summary:
Badger Meter, Inc. (BMI) exhibits hallmarks of high quality, operating in an oligopolistic water-metering market providing must-have solutions, replacement-driven recurring revenue, and attractive free-cash-flow generation. Decades of consistent execution and recurring revenues support durable compounding.

BSD Analysis:
Badger Meter supplies smart water meters and flow solutions tied to infrastructure modernization. Municipal customers move slowly but stick forever. Regulatory pressure and water scarcity drive adoption. Recurring software and service revenue improve margins. Investors overlook Badger due to boring optics. Yet replacement cycles are long and predictable. Data analytics increase value per install. This is infrastructure tech with secular tailwinds. Quiet compounding beats hype.

Pitch Summary:
FirstService Corp. (FSV) detracted from performance after the company reported third-quarter revenues that fell short of consensus expectations, despite meeting earnings per share estimates. Investors expressed concern over softer organic growth and near-term headwinds in certain service lines.

BSD Analysis:
FirstService operates essential property services that homeowners and HOAs can’t ignore. Recurring contracts provide cash flow stability. Fragmentation creates acquisition opportunities. Weather and housing cycles add noise. But maintenance demand persists regardless. Scale improves route density and margins. Investors undervalue boring service businesses. Capital allocation has been disciplined. This is real estate services with compounding characteristics.

Pitch Summary:
Repligen Corp. (RGEN) rebounded strongly as evidence mounted that industry destocking had bottomed and order trends were stabilizing. Improved visibility into 2026 growth, combined with disciplined cost controls, drove operating leverage expectations higher. The market re-rated the stock as investors looked past near-term volatility and focused on RGEN’s high-quality consumables mix and long-term biologics growth tailwinds.

BSD Analysis:
Repligen sits upstream of biologics manufacturing, supplying components customers won’t swap casually. Funding slowdowns hit volumes, but complexity protects relevance. Contamination risk keeps switching costs high. Margins reflect technical specialization. Investors panic over destocking cycles. But biologics pipelines keep growing. When production restarts, demand rebounds sharply. Operating leverage cuts both ways. This is a life sciences tollbooth paused, not broken.

Pitch Summary:
RBC Bearings, Inc. (RBC) was a standout contributor as aerospace demand remained resilient, defense orders accelerated, and operating leverage drove margin expansion. Investors reacted positively to strong free-cash-flow conversion and continued successful integration of prior acquisitions. RBC’s exposure to long-cycle aerospace programs and mission-critical components supported earnings durability.

BSD Analysis:
RBC Bearings supplies precision components where failure is not tolerated. Aerospace exposure adds cyclicality, but also high margins and long program lives. Switching suppliers is costly and risky for OEMs. Investors focus on near-term aerospace recovery timing. Meanwhile, backlog and content per aircraft keep rising. Industrial diversification smooths demand swings. Margins reflect engineering depth, not commodity inputs. As production rates normalize, leverage is meaningful. This is manufacturing with real barriers.

Pitch Summary:
Clearwater Analytics Holdings, Inc. (CWAN) significantly outperformed during the quarter following the announcement that the company would be acquired, which drove a re-rating toward the agreed transaction value. The acquisition highlighted the strategic value of CWAN’s highly recurring revenue model, strong client retention, and critical role within institutional investment operations.

BSD Analysis:
Clearwater sells mission-critical investment accounting software to institutions that value accuracy over aesthetics. Once installed, it becomes the system of record, making churn rare. Growth is steady, driven by asset complexity rather than market exuberance. Clients include insurers, asset managers, and governments with long sales cycles and long lives. Margins expand as implementations give way to subscription revenue. Investors dismiss Clearwater as slow SaaS. But slow plus sticky is a powerful combination. Rising regulation increases demand for clean reporting. This is financial plumbing that compounds quietly.

Pitch Summary:
Generac Holdings, Inc. (GNRC) was a notable detractor as residential generator demand weakened due to fewer power outage events and a normalization of post-pandemic demand. Management reduced full-year guidance, citing softer volumes in the core home standby business. While the commercial and industrial segment continued to show strength, particularly tied to data center demand, near-term earnings pressure dominated sentiment. We continue to view Generac as a long-term beneficiary of energy resiliency and grid instability, but cyclical headwinds weighed heavily in the quarter.

BSD Analysis:
Generac is paying the price for mistiming an extreme demand cycle, not for selling a useless product. Grid instability, weather volatility, and electrification all favor backup power long term. Residential demand cooled hard, forcing painful inventory and margin resets. Investors extrapolate disappointment into permanent decline. The installed base creates service and replacement demand that compounds quietly. Commercial and industrial applications diversify exposure. Distributed energy systems add optional upside. This business sells insurance against failure. Failure is becoming more common.

Pitch Summary:
Bentley Systems, Inc. (BSY) traded lower during the quarter as revenue growth decelerated modestly and margins were impacted by increased investment in product development and go-to-market initiatives. Investor concerns centered on project timing delays and variability in public-sector infrastructure spending. While near-term execution weighed on results, Bentley’s subscription-based model continues to generate high recurring revenue. The company remains well positioned to benefit from long-term global infrastructure investment trends. Market weakness reflected valuation compression rather than a deterioration in competitive positioning.

BSD Analysis:
Bentley runs mission-critical design software for infrastructure assets that last decades. Once embedded in a project, Bentley tools remain through the entire lifecycle. Revenue is recurring, global, and tied to long-duration infrastructure spend. Growth isn’t flashy, but retention is elite. Investors compare Bentley to faster SaaS names and miss durability. Digital twins and asset optimization add incremental value over time. Government and utility customers don’t churn lightly. Margins improve slowly as scale builds. This is software for things that can’t fail.

Pitch Summary:
CoStar Group, Inc. (CSGP) experienced share price pressure due to heavy investment in its Homes.com platform. Elevated marketing spend weighed on near-term profitability, while Apartment.com bookings disappointed expectations. Investor concerns were amplified by reports that large technology platforms could enter residential listings. While management views residential expansion as a long-term growth opportunity, the investment burden reduced near-term earnings visibility. Sentiment reflected margin pressure rather than asset quality.

BSD Analysis:
CoStar is the data monopoly of commercial real estate, even while CRE sentiment collapses. Transaction volumes swing, but data subscriptions are sticky because professionals can’t operate blind. The company reinvests aggressively, which depresses margins but deepens the moat. Residential expansion through Homes.com is expensive but strategic. Investors worry about near-term ROIC instead of long-term dominance. CRE distress actually increases demand for high-quality data. Switching costs are cultural as much as technical. CoStar doesn’t optimize for quarters; it optimizes for inevitability. This is information infrastructure priced like a cyclical.

Pitch Summary:
Veeva Systems, Inc. (VEEV) underperformed during the quarter despite maintaining a dominant market position and raising full-year guidance. Shares declined as investors rotated away from higher-valuation software names and expressed caution over the timing of large enterprise deal closures. Near-term growth visibility was questioned despite strong fundamentals. We continue to view VEEV as strategically critical to life sciences customers, with a broadening product runway. Short-term sentiment rather than fundamentals drove weakness.

BSD Analysis:
Veeva owns the operating system of regulated life sciences, where compliance risk creates brutal switching costs. CRM is just the entry point; quality, clinical, and regulatory modules drive expansion. Growth slowed as biotech funding tightened, testing investor patience. But customers don’t abandon systems that regulators expect to see. Pricing power exists because failure is not an option. Margins reflect software economics layered onto mission-critical workflows. Investors treat Veeva like generic SaaS, which misses the moat. As pipelines restart, growth reaccelerates quietly. This is regulated software compounding at its own pace.

Pitch Summary:
Pool Corp. (POOL) detracted from performance as demand remained pressured by a slower housing and discretionary spending environment. New pool construction and renovation activity declined, weighing on volumes. While the company’s maintenance business remained resilient, deflation in pool chemicals negatively impacted revenue. Despite near-term headwinds, POOL continues to generate strong cash flow and benefits from scale and distribution advantages. However, cyclical pressures dominated investor sentiment during the quarter.

BSD Analysis:
Pool Corp is a logistics and distribution machine masquerading as a pool business. Once a pool is built, maintenance demand becomes non-discretionary and recurring. Weather and housing cycles add noise, but the installed base keeps expanding. Scale gives Pool purchasing power and same-day availability competitors can’t match. Investors panic when new pool construction slows. But repairs, chemicals, and parts don’t disappear. Margin discipline reflects execution, not luck. Cash flow remains resilient through cycles. This is boring infrastructure tied to leisure assets that don’t go away.

Pitch Summary:
West Pharmaceutical Services, Inc. (WST) performed strongly as momentum in its High-Value Products segment continued. Demand tied to GLP-1 obesity and diabetes therapies supported growth. Management noted that prior destocking headwinds have moderated, improving volume visibility. The company’s role as a critical supplier to pharmaceutical manufacturers remains intact. We believe WST is well positioned to benefit from long-term trends toward biologic and injectable medicines.

BSD Analysis:
West sits at the unglamorous but indispensable intersection of drug delivery and patient safety. Its containment and delivery systems are tiny components with enormous consequences, which creates real pricing power. Demand softened as COVID volumes rolled off, exposing cyclicality investors weren’t prepared for. But biologics, injectables, and self-administration trends remain intact. Switching suppliers introduces regulatory and contamination risk most pharma companies won’t take. Margins are protected by technical depth and validation requirements. Investors confuse normalization with erosion. As biologics pipelines advance, West’s relevance increases, not fades. This is pharma picks-and-shovels with patience-tested value.

Pitch Summary:
IDEXX Laboratories, Inc. (IDXX) was a major contributor during the quarter as it continued to deliver resilient organic revenue growth despite weaker veterinary visit trends. The company posted robust quarterly results, reinforcing its leadership position in veterinary diagnostics. Consumables adoption and instrument placement supported recurring revenue growth. Shares re-rated toward historical valuation averages as confidence in earnings durability improved. We believe IDEXX remains a high-quality defensive growth asset within health care.

BSD Analysis:
IDEXX is the quiet monopoly in companion animal diagnostics, and the market still underestimates how locked-in its customers really are. Vet clinics don’t rip out diagnostic workflows once they’re embedded, which makes recurring revenue incredibly durable. Growth slows when pet adoption normalizes, but testing intensity per visit keeps rising. Pricing power exists because outcomes matter more than cost in animal health. The installed base acts like an annuity with incremental software and consumables layered on top. Investors worry about valuation every cycle and then watch it hold anyway. Margins reflect IP and switching costs, not volume chasing. IDEXX doesn’t need growth heroics to work. This is healthcare infrastructure for pets, priced like a growth stock for a reason.